Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2026 · third_quarter · Q3
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety; illicit compounding; FDA destruction authorities; the SAFE Drugs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2026 · second_quarter · Q2
Source: Senate LDA
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety; illicit compounding; FDA destruction authorities; the SAFE Drugs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2026 · first_quarter · Q1
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2025 · fourth_quarter · Q4
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2025 · third_quarter · Q3
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2025 · second_quarter · Q2
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2025 · first_quarter · Q1
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2024 · fourth_quarter · Q4
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2024 · third_quarter · Q3
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2024 · second_quarter · Q2
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2024 · first_quarter · Q1
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2023 · fourth_quarter · Q4
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2023 · third_quarter · Q3
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2023 · second_quarter · Q2
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2023 · first_quarter · Q1
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2022 · fourth_quarter · Q4
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2022 · third_quarter · Q3
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2022 · second_quarter · Q2
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2022 · first_quarter · Q1
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2021 · fourth_quarter · Q4
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2021 · third_quarter · Q3
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2021 · second_quarter · Q2
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2021 · first_quarter · Q1
Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES via STACEY BARRACK D/B/A STACEY BARRACK
2021 · first_quarter · RR
Issues related to counterfeit medicines and products, drug pricing, Prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability